CL Stock Alert: Colgate-Palmolive Reportedly Considers $1 Billion Brand Sale
Colgate-Palmolive (CL) is reportedly exploring the sale of non-core personal care brands, valued at over $1 billion, with Goldman Sachs' advisory. The move aims to reallocate capital toward higher-growth segments. CL shares are down 12% year-to-date, trading below major moving averages, but offer a 2.44% dividend yield. Institutional investors remain bullish, and the consensus rating is 'Moderate Buy' with a mean price target of $160.
How this was made

The 30-second read
Why it matters
The announced divestiture could unlock value and improve cash flow, supporting a higher target price.
Market read
A $1B+ brand sale is a material corporate action for a large‑cap consumer staple, likely to affect CL and its peers.
What to watch
Execution risk, tax implications, and potential buyer interest are uncertain.
Background
Colgate-Palmolive has underperformed YTD, down ~12% from its high, and is seeking growth avenues.
Ticker impact
Colgate-Palmolive is exploring a $1B+ sale of non‑core personal‑care brands, a fresh strategic divestiture.
Short‑term upside pressure if the sale is confirmed; medium‑term support for valuation.
Large‑scale asset sale signals capital redeployment and margin improvement for a lagging stock.
Market effects
May prompt other consumer‑goods peers to consider portfolio rationalization.
U.S. consumer staples sector could see modest re‑rating.
Limited to consumer‑goods equities worldwide.
Counterpoint
Deal could be delayed or canceled, leaving CL vulnerable to continued margin pressure.
Key entities
- Advisory FirmGoldman Sachs
Financial adviser for the potential brand sale.



